RBC Affirms PTC Therapeutics (PTCT) at 'Sector Perform'; Doesn't See Translarna Appeal with Solid Chance

October 17, 2016 11:21 AM EDT Send to a Friend
RBC Capital affirms PTC Therapeutics, Inc. (Nadaq: PTCT) at Sector Perform with a price target of $5 after the company ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login